In Silico Design of a Trans‐Amplifying RNA‐Based Vaccine against SARS‐CoV‐2 Structural Proteins
Advances in Virology · 2024-01 · 2024 (1)
DOI: 10.1155/2024/3418062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Virology, online erschienen am 29.09.2024. Verfasst von Fatemeh Nafian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences Faculty of Paramedics Tehran Medical Sciences Islamic Azad University, Tehran, Iran. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahrekord University of Medical Sciences.
Abstract (Originalsprache)
Nucleic acid‐based vaccines allow scalable, rapid, and cell‐free vaccine production in response to an emerging disease such as the current COVID‐19 pandemic. Here, we objected to the design of a multiepitope mRNA vaccine against the structural proteins of SARS‐CoV‐2. Through an immunoinformatic approach, promising epitopes were predicted for the spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. Fragments rich in overlapping epitopes were selected based on binding affinities with HLA classes I and II for the specific presentation to B and T lymphocytes. Two constructs were designed by fusing the fragments in different arrangements via GG linkers. Construct 1 showed better structural properties and interactions with toll‐like receptor 2 (TLR‐2), TLR‐3, and TLR‐4 during molecular docking and dynamic simulation. A 50S ribosomal L7/L12 adjuvant was added to its N‐terminus to improve stability and immunogenicity. The final RNA sequence was used to design a trans‐amplifying RNA (taRNA) vaccine in a split‐vector system. It consists of two molecules: a nonreplicating RNA encoding a trans‐acting replicase to amplify the second one, a trans‐replicon (TR) RNA encoding the vaccine protein. Overall, the immune response simulation detected that activated B and T lymphocytes and increased memory cell formation. Macrophages and dendritic cells proliferated continuously, and IFN‐ γ and cytokines like IL‐2 were released highly.
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences Faculty of Paramedics Tehran Medical Sciences Islamic Azad University, Tehran, Iran.
- Department of Biological Sciences Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
- Department of Biology Technical University of Kaiserslautern, Kaiserslautern Technical University of Kaiserslautern, Kaiserslautern, Germany.
- Department of Cellular and Molecular Biology Faculty of Advanced Sciences and Technology Tehran Medical Sciences Islamic Azad University, Tehran, Iran.
- Department of Stem Cell and Regenerative Medicine National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
- Department of Biotechnology Faculty of Converging Sciences and Technologies Science and Research Branch Islamic Azad University, Tehran, Iran.
ORCID-Profile: Fatemeh Nafian, Zahra Pourmanouchehri
Förderung
- Shahrekord University of Medical Sciences
Zitieren
APA
Nafian, F., Soleymani, G., Pourmanouchehri, Z., Kiyanjam, M., Nafian, S., Mohammadi, S. M., Jeyroudi, H., Berenji Jalaei, S., & Sabzpoushan, F. (2024). In Silico Design of a Trans‐Amplifying RNA‐Based Vaccine against SARS‐CoV‐2 Structural Proteins. Advances in Virology, 2024(1). https://doi.org/10.1155/2024/3418062
Vancouver
Nafian F, Soleymani G, Pourmanouchehri Z, Kiyanjam M, Nafian S, Mohammadi SM, et al. In Silico Design of a Trans‐Amplifying RNA‐Based Vaccine against SARS‐CoV‐2 Structural Proteins. Advances in Virology. 2024;2024(1). doi:10.1155/2024/3418062
BibTeX
@article{Nafian2024,
author = {Nafian, Fatemeh and Soleymani, Ghazal and Pourmanouchehri, Zahra and Kiyanjam, Mahnaz and Nafian, Simin and Mohammadi, Sayed Mohammad and Jeyroudi, Hanie and Berenji Jalaei, Sharareh and Sabzpoushan, Fatemeh},
title = {In Silico Design of a Trans‐Amplifying RNA‐Based Vaccine against SARS‐CoV‐2 Structural Proteins},
journal = {Advances in Virology},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/3418062}
}
EUVIMED